Jack Kaye

CIK 1376099 · last filed 2026-07-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.80M

Companies

3

Total Filings

57

Lifetime Open-Market Net

-$3.15M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QURE Director 43,056 $39.71 $1.71M -$2.96M 24 2026-07-02
DYAI Director 81,201 $1.07 $86.9K $0 10 2026-01-06
KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Director 86,400 -$195.8K 17 2015-06-18

Recent Filings · Page 2 of 6

57 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-01-06 DYAI Mixed +21,552 $0 EDGAR
2025-11-06 QURE Mixed -$794.0K EDGAR
2025-11-04 QURE Notice (144) −38,810 -$1.33M EDGAR
2025-06-24 QURE Sell (S) −2,112 -$30.5K EDGAR
2025-06-13 QURE Grant (A) +7,970 $0 EDGAR
2025-03-07 DYAI Mixed +2,483 $0 EDGAR
2025-01-07 DYAI Mixed +23,585 $0 EDGAR
2024-06-21 QURE Grant (A) +8,080 $0 EDGAR
2024-06-17 QURE Sell (S) −2,218 -$11.4K EDGAR
2024-01-04 DYAI Mixed +27,174 $0 EDGAR
Showing 1120 of 57
Page 2 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.